CZ48 (Camptothecin-20-O-propionate hydrate)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CZ48 (Camptothecin-20-O-propionate hydrate), covering 2015-06-18 to 2015-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma [Phase 1]